Introduction

Unicompartmental knee arthroplasty (UKA) has gained renewed interest in the past decade as an alternative to total knee arthroplasty (TKA) for selected patients with degenerative joint disease limited to the lateral or medial compartment of the knee [4, 33, 36]. The advantages of UKA over TKA are reduced blood loss, less perioperative morbidity, faster recovery and rehabilitation, as well as increased postoperative range of motion compared to total knee arthroplasty [6, 10, 17, 26, 34, 42]. Historically, obesity was thought to result in suboptimal clinical outcomes and increased revision rates following conventional UKA using manual instrumentation [5, 6, 24]. More recent studies have continued to support obesity as a contraindication to UKA. In a consecutive patient series, Bonutti et al. [9] found lower implant survival rates in patients with BMI >35 at a minimum 2-year follow-up. Kandil et al. [27] reviewed a large national database including 1823 obese and 1019 morbidly obese patients and found increased medical complications and early revision rates compared to non-obese patients. However, the concurrent literature in recent years has challenged the indications for UKA to include patients with a higher BMI [11, 12, 39]. At an average 12-year follow-up, Cavaignac et al. [11] found no difference in UKA survival rates between patients with BMIs over or under 32. Murray et al. [39] assessed outcomes in 2438 mobile-bearing UKAs stratified by patient BMI and found no association between failure rate and BMI at mean 5-year follow-up.

The impact of obesity on the outcomes of robotic-assisted UKA has not been assessed. Robotic-assisted systems are available for UKA and have been shown to improve component positioning compared to conventional manual UKA procedures [15, 17, 31, 35, 43, 48]. UKA is technically challenging, and precise component placement is vital for implant survival [3, 17, 32, 36, 37, 47, 55], where over- or under-correction by as little as 2° may lead to improper component placement, possibly increasing polyethylene wear of the tibial component, leading to progression of osteoarthritic changes in other compartments of the knee, or causing anterior knee pain [3, 16, 17, 25, 34, 37, 41, 42, 46]. In cadaveric and clinical studies, robotic-assisted UKA was found to have less variability in implant position compared to manual component insertion by the same surgeon [14, 35]. In addition, robotic-assisted UKA provides an objective method to perform accurate soft tissue balancing during the procedure [45]. The improved component positioning accuracy afforded by robotic systems may be particularly advantageous in obese patients with increased stresses at the bone–implant interface [20].

The purpose of this study was to assess the influence of obesity on the outcomes of UKA with a robotic-assisted system at a single institution. We hypothesized that increased body mass index (BMI) does not influence the outcomes of robotic-assisted UKA and that outcomes are comparable to conventional UKA recorded in various national joint registries.

Materials and methods

The joint registry at a single university medical centre was analysed for patients who underwent robotic-assisted UKA (MAKO Surgical Corp., Ft Lauderdale, FL) between 2008 and 2012 by four surgeons. Current author indication included patients generally older than 40 years of age, medium to high preoperative activity levels, no anterior cruciate ligament instability or pivot shift, less than 15 degrees of varus deformity and less than 15 degrees of flexion contracture, and no weight restrictions. The implants consisted of cemented, fixed-bearing femoral and tibial components with InLay or OnLay based on surgeon preference. Patients who received a medial compartment UKA and had a minimum of 24 months of follow-up were stratified according to BMI. There were seven weight categories based on a clinical modification of the World Health Organization classification system [56].

Patient demographics including age, Charlson comorbidity index, American Society of Anesthesiologists physical status classification system (ASA), length of hospitalization and Oxford knee score at final follow-up were retrieved from patients’ medical records. All patient medical records were assessed for length of surgery (incision to closure time), 90-day mortality and readmissions, postoperative complications, and revision surgery. Patients’ opioid pain medication requirements for the first 3 days after surgery and the number of physical therapy sessions required to reach discharge goals were recorded for each patient. The amount of oral and intravenous opioid pain medication was converted to morphine equivalent doses (MED) based on available conversion tables [13, 44]. Patients were followed in clinic at 2 months, 6 months and 1 year after surgery and then annually. Patients who were not seen in clinic for more than 6 months (27 %) from the time of this investigation were contacted by phone to acquire Oxford knee scores and inquire about possible revision surgery. Institutional Review Board approval from Wake Forest Baptist Health was obtained prior to the beginning of this study (IRB 2873).

Statistical analysis

Data are reported as the mean ± standard deviation (SD) for continuous variables and as percentages for categorical variables. Chi-square analysis was used to assess the influence of BMI on postoperative complications, revision surgeries and 90-day readmissions. Correlation analysis was used to analyse the influence of BMI on length of surgery and hospitalization. Statistical analysis was performed with alpha 0.05 (Prism 6, GraphPad, LaJolla, CA, USA).

Results

A total of 1032 medial robotic-assisted UKAs were performed in the study period. A total of 746 UKAs (672 patients) had >24 months of follow-up and were included in this study (Table 1). There were 595 InLay prosthesis and 151 OnLay designs. There was no correlation between length of surgery and BMI (n.s.) or length of hospitalization and BMI (n.s.). There was a significant correlation between increasing BMI and higher ASA score (p < 0.001), but there was no correlation between Charlson comorbidity index and BMI (p = 0.096; Table 2).

Table 1 Patient demographics and hospitalization
Table 2 Patient body mass index and comorbidities

Opioid medication requirement was highest following surgery including postoperative day 1 (28.3 ± 25.0 MED, n = 743) and significantly decreased (p < 0.05) on postoperative day 2 (20.5 ± 22.1 MED, n = 472). Opioid requirements were similar on postoperative day 3 (16.1 ± 19.2 MED, n = 118). There was a significant correlation between increasing BMI and higher opioid medication requirements following surgery including on postoperative day 1 (p = 0.002), on postoperative day 2 (p = 0.007) and on postoperative day 3 (p = 0.007). Patients required a mean of 2.1 ± 1.3 physical therapy sessions to reach discharge goals which correlated with increasing BMI (p = 0.031). The mean Oxford knee score at final follow-up was 37 ± 11 (range 2–48) and did not correlate with patient’s BMI (p = 0.387).

Patient’s BMI did not influence the rate of revision surgery to TKA or conversion from InLay to OnLay design (n.s.) (Table 3). There were 43 revisions to total knee arthroplasty (5.8 %) in the entire group (Table 4). Of 595 InLay prostheses, 11 were converted from an InLay to an OnLay design (1.8 %; Table 4); two patients subsequently underwent revision to TKA. The type of prosthesis (InLay/OnLay) regardless of patient BMI had no influence on revision rate to TKA (n.s.) or all revision surgery (n.s.). Two patients received a robotic-assisted patellofemoral arthroplasty during revision from InLay to OnLay design. One patient with an InLay prosthesis (0.1 %) and another patient with an OnLay prosthesis (0.1 %) underwent open arthrotomy for removal of cement and osteophytes causing mechanical symptoms and pain.

Table 3 Body mass index and revision surgeries
Table 4 Reasons for revision surgery

There were four infections (0.5 %) in this study in patients with BMIs ranging from 23.6 to 29.8. Two patients with an OnLay prosthesis underwent open irrigation and debridement with polyethylene liner exchange which resolved the infection. One patient with an InLay prosthesis underwent open irrigation and debridement and received intravenous antibiotics which resolved the infection. Another patient with an InLay prosthesis underwent arthroscopic irrigation and debridement and subsequently required revision to TKA.

A total of 37 patients (5.0 %) in this study underwent arthroscopy following robotic-assisted UKA: 36 for pain and mechanical symptoms (97 %) and one for infection (3 %). BMI was not associated with the need for arthroscopy (n.s.); however, all arthroscopies were in patients who received an InLay prosthesis (p < 0.001). Two patients subsequently required conversion from an InLay to OnLay design, and two patients required revision to TKA.

The femoral component design was changed by the manufacturer during the course of this investigation. Of all 43 revisions to TKA, 21 patients (49 %) had received a femoral component with one peg and 22 patients (51 %) had received a newer component with two pegs.

There were a total of 34 readmissions (4.4 %) that occured within 90 days after surgery without correlation with BMI (n.s.) (Table 5).

Table 5 Ninety-day readmissions

Discussion

The most important finding of the current study was that BMI had no influence on the short-term to mid-term clinical outcomes and readmission rates of patients who underwent medial robotic-assisted UKA. This study is the first to assess the effects of BMI on outcomes after robotic-assisted UKA, and these findings concur with previous studies assessing the influence of BMI on conventional UKA, which found no association between BMI and failure rate [39, 50]. The revision rate of the current study is similar to the reported revision rates of national registries [2, 40]. Therefore, the classic contraindication of a BMI >30 kg/m2 may not be justified with the use of robotic-assisted UKA designs. Furthermore, BMI had no effect on length of hospital stay, length of surgery or 90-day readmission rate. However, increased BMI was associated with increased narcotic pain medication requirements and utilization of physical therapy resources prior to discharge.

The outcomes of UKA with early component designs were shown to be influenced by patient BMI, and as a result, a weight restriction of 82 kg was recommended by Kozinn and Scott [29] to avoid early prosthesis failure. Deshmukh and Scott [11, 21] increased this weight restriction to 90 kg. In an analysis of 73 medial UKAs with a fixed-bearing design in 61 patients with a minimum follow-up of 2 years, BMI of >32 was identified as a causative factor for early failure [5]. Bonutti et al. [9] compared fixed-bearing UKAs in 34 patients (40 UKAs) with a BMI of ≥35 kg/m2 with 33 patients (40 UKAs) who had a BMI of <35 kg/m2. Obese patients had a 12.5 % higher failure rate after a minimum follow-up of 24 months compared with non-obese patients [9]. Failures resulted from progression of painful arthritis, tibial component loosening and intractable pain which the authors attributed to improper component alignment [9]. The most common reason for revision to TKA in the current study was intractable pain (46 %) and tibial component loosening (12 %). However, there was no association between BMI and reason for failure in the current study (p < 0.05).

The current literature is equivocal for outcomes following fixed- and mobile-bearing UKA designs. Fixed-bearing designs appear to have improved long-term survivorship with more consistent results and are technically less challenging to perform [8]. However, newer mobile-bearing designs, while more challenging to perform, may deliver promising results in patients with higher BMI’s secondary to the prosthesis maintaining more native joint mechanics that preserve adequate contact between UKA components throughout range of motion to reduce pressure and bone-prosthesis stress [18, 23, 30, 53]. In an analysis of 2438 UKAs with a mobile-bearing prosthesis at a mean follow-up of 5 years, BMI did not influence the revision rate [39]. The authors concluded that BMI as a surgical limitation should be abandoned [39]. In a study of 100 UKAs in 82 patients stratified according to BMI and followed over a period of 20 years, obese patients had a decreased revision rate [52]. Emerson et al. [22] observed a decreased revision rate in mobile-bearing designs in patients with increased BMI and concluded that tibial component failure may be reduced in mobile-bearing UKAs. The findings of the current study with a fixed tibial component suggest that patient BMI does not influence outcomes; however, long-term follow-up with robotic-assisted fixed-bearing designs will be needed.

The current literature is ambivalent about which tibial component design is most efficacious in obese patients. The tibial resection is more extensive for an OnLay design, while the all-polyethylene InLay design preserves tibial bone. However, the advantage of decreased bone resection with the InLay design might be negated by increased interface stresses between the polyethylene insert and tibial bone surface, which may be increased in obese patients based on the axial force across the interface [49, 54]. Previous studies revealed improved mechanical alignment with an OnLay design which could prolong implant survival [19, 51]. In a study of 1746 UKAs, OnLay components were found to have a decreased revision rate at a median of 3.6 years [7]. However, Murray et al. [38] compared 207 InLay to 202 OnLay UKAs and found similar revision rates. Aleto et al. [1] retrospectively analysed failed UKAs and reported premature failure in all-polyethylene tibial implants. While various reports state that the difference between the failure rates of OnLay and InLay appeared to be significant even after BMI was adjusted, some studies suggest that there is no difference. In the current study, the type of prosthesis, regardless of patient BMI, had no statistically significant influence on revision rate (p = 0.069). However, a trend can be noted towards InLay prosthesis having a higher number of revision surgeries including revision to TKA and conversion of an InLay to OnLay design. In addition, there were a significantly higher number of patients with an InLay component that required arthroscopy following UKA for pain and mechanical symptoms.

The overall revision rate of UKA to TKA in the current study is comparable (p = 0.785) to reported revision rates of conventional UKA in national registries at 3-year follow-up (4.7 % to approx. 6.5 %, Table 6). However, specific designs are typically not reported in these registries limiting their application to this comparison. Future studies will need to assess the effect of precise component positioning and ligament balancing using a robotic-assisted system on the long-term outcomes UKA in patients with elevated BMI.

Table 6 Comparison of UKA revision rates reported in national registries

This study has various limitations that need to be considered when interpreting the findings. The majority of UKAs in this study were performed by one surgeon (60 %) and were mainly InLay design UKAs (96 %), while the OnLay design UKAs were performed by three other surgeons (70; 23; 7 %). Surgeon experience was found to be a key factor for UKA success. In a study comparing 72 InLay with 75 OnLay UKAs, surgeon experience (more than 50 UKA/year vs. <10 UKA/year) and correct component positioning were determining factors for implant survival, not the implant design [57]. Robotic-assisted surgery decreases the learning curve for surgeons, which may reduce the effect of surgeon experience on implant survivorship [28]. In combination with improved component positioning, surgeons with limited experience performing UKA may benefit from robotic-assisted surgery. Furthermore, the majority of UKAs in this study were InLays (80 %), while the most commonly used UKA design is OnLay, limiting the generalizability of the results of this study. The femoral component design was changed by the manufacturer during the course of this investigation. However, there was no difference in the number of revision surgeries to TKA between the two designs. This study does not include a radiographic analysis of the failure mechanism of robotic-assisted medial UKA, which will be addressed in future studies. The mean short-term follow-up time of this study was 36 months. Long-term studies will be needed to evaluate the success of robotic-assisted fixed-bearing UKAs compared to conventional mobile-bearing UKAs.

Conclusion

Based on the findings of the current study, BMI had no influence on the clinical outcomes, length of hospital stay or readmission rates of patients who underwent medial robotic-assisted UKA with short-term follow-up. However, increasing BMI was associated with higher hospital resource utilization and narcotic pain medication requirements. Obesity may not be justified as a contraindication to UKA.